Cytome analysis to accelerate discovery for therapeutics development and validate novel diagnostic strategies.
My ongoing research projects cover innovative approaches to study the expression of primitive stem cell markers during origin, progression, maintenance of cancer and its management; the quality and safety assessment of hematopoietic blood progenitors, stem cell grafts and immune recovery after transplantation; the role of myeloid derived suppressor cells in immunotherapy and targeted therapy for clinical decision-making; new cytomic strategies for whole blood and marrow immunophenotyping; the use of natural compounds for cancer treatment and boost the immune system; the accurate detection and significance of measurable residual disease in cancer; and the impact of plastic pollution and its effects and the immune response.
Contact Information:
